Shift-Work Sleep Disorder Clinical Trial
— tDCS-SWORDOfficial title:
Transcranial Direct Current Stimulation Therapy for Sleepiness Related to Shift Work Disorder (tDCS-SWORD)
NCT number | NCT03879044 |
Other study ID # | 2018H0139 |
Secondary ID | |
Status | Terminated |
Phase | N/A |
First received | |
Last updated | |
Start date | March 20, 2019 |
Est. completion date | June 20, 2020 |
Verified date | October 2021 |
Source | Ohio State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
1. To determine the effects of tDCS on subjective measures of sleepiness in night-shift workers with shift work disorder. 2. To determine the effects of transcranial direct current stimulation (tDCS) on vigilance in night-shift workers with shift work disorder.
Status | Terminated |
Enrollment | 30 |
Est. completion date | June 20, 2020 |
Est. primary completion date | June 20, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - age 18-65 years - works 5 or more night shifts per month (each shift lasting at least 10 hours, with =6 hours worked between 10 pm and 8 am) with plans to maintain this schedule for the duration of the 3-week trial - meets the criteria for Shift Work Disorder according to the International Classification of Sleep Disorders24 and evaluation of a sleep medicine provider (physician or nurse practitioner) during a screening evaluation: 1. affirmative answers to Do you experience excessive sleepiness? (yes/no); "Do you experience difficulties with falling asleep during opportunities for sleep? (yes/no); "Is the sleep or sleepiness problem related to a work schedule where you have to work when you would normally sleep? (yes/no)"; and "Has this sleep or sleepiness problem related to your work schedule persisted for at least three months? (yes/no) 2. based on the evaluation of the sleep medicine provider, the sleep and/or wake disturbance are not better explained by another current sleep disorder, medical or neurologic disorder, mental disorder, medication use, poor sleep hygiene, or substance abuse disorder. - Stable medication dosage over previous 4 weeks. - Able to understand English and give a written informed consent document. Exclusion Criteria: - Currently taking stimulant medications such as Modafinil, Armodafinil, Methylphenidate, or Dextroamphetamine. - History of automobile accident due to falling asleep while driving - Inability to understand or read English - Self-reported Substance abuse (current) - Excessive alcohol consumption defined as: - More than 3 glasses of wine a day - More than 3 beers a day - More than 60 mL of hard liquor a day - Presence of cardiac pacemaker or automatic implantable cardioverter-defibrillator (AICD). - Pregnancy, lactation (will be screened with urine pregnancy test) - Non-removable metal or tattoos around head - Use of implantable birth control device such as Implanon - History of frequent severe headaches - Unstable coronary artery disease - Uncontrolled Seizure disorder - Uncontrolled hypertension - Any other clinically significant condition that, in the opinion of the Investigator, might put the subject at risk of harm during the study or might adversely affect the interpretation of the study data. |
Country | Name | City | State |
---|---|---|---|
United States | The Ohio State University | Columbus | Ohio |
Lead Sponsor | Collaborator |
---|---|
Ohio State University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Psychomotor Vigilance Test | Objective measure of sleepiness. Scale ranges between each individual, with the reciprocal of the reaction time being reported. | 3 minutes | |
Primary | Karolinska Sleepiness Scale | Subjective measure of sleepiness. Scale ranges from 1-9, with total score being reported. | 5 minutes | |
Secondary | Epworth Sleepiness Scale | Subjective measure of sleepiness. The scale ranges from 0-24, with the total score being reported. | 5 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01672502 -
Fire Fighter Fatigue Management Program: Operation Fight Fatigue
|
N/A | |
Completed |
NCT02978053 -
Light Treatment to Shift-working Nurses
|
N/A | |
Completed |
NCT00786266 -
Sleep Enhancement Training Study for Novice Shiftworkers
|
Phase 1 | |
Completed |
NCT00786357 -
Sleep Enhancement Training Study for Experienced Shiftworkers
|
Phase 1 | |
Completed |
NCT00900159 -
Effects of Daytime Eszopiclone Administration in Shift Workers
|
N/A | |
Completed |
NCT01988129 -
Fire Fighter Fatigue Management Program: Operation Healthy Sleep
|
N/A | |
Completed |
NCT02541747 -
Assessments in Stress and Quality of Sleep/Life in Night-shift Nurses and Doctors
|
Phase 4 | |
Completed |
NCT03153917 -
Biological Rhythms Impact of 12 Hours Shift Work
|
N/A | |
Recruiting |
NCT03956745 -
Biomarkers for Circadian Timing in Healthy Adults
|
||
Active, not recruiting |
NCT03980340 -
Breath Biomarkers for Sleep Loss and Circadian Timing
|
||
Completed |
NCT02901860 -
Shift Work and Risk of Cardio-vascular Disease
|
||
Completed |
NCT00078312 -
Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
|
Phase 3 | |
Recruiting |
NCT06231641 -
The Effects of Lemborexant on the Ability to Sleep During Daytime
|
Phase 2 | |
Recruiting |
NCT04693182 -
Health Promoting Work Schedules: The Effect of Abolishing Quick Returns
|
N/A | |
Not yet recruiting |
NCT03087435 -
Well-Being in Medical Residents in the HIBA
|
||
Terminated |
NCT01264913 -
Cardiometabolic Risk of Shiftwork
|
N/A | |
Completed |
NCT03813654 -
Sleep and Circadian Treatments for Shift Workers
|
N/A |